Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ADC Therapeutics SA ADCT

Full chart Compare
Set alert

Price alert · ADCT

All alert types
1.55 USD +0.01 (+0.65%)

At closeNov 3, 2026, 4:01 PM EST

1.55 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

1.53 Day range 1.66
0.96 52-week range 4.88
YTD
-56.09%
1 year
-62.92%

Financial health

Altman Z-Score

-8.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -3.2×
FY 2016: 0.0×FY 2017: -19.4×FY 2018: -12.9×FY 2019: -17.0×FY 2020: -8.5×FY 2021: -6.7×FY 2022: -1.9×FY 2023: -0.6×FY 2024: -1.2×FY 2025: -3.2×
FY 2016 5y median -1.9× FY 2025
P/S 5.5×
FY 2016: 0.0×FY 2017: 968×FY 2018: 1400×FY 2019: 847×FY 2020: 0.0×FY 2021: 45.7×FY 2022: 1.4×FY 2023: 2.0×FY 2024: 2.7×FY 2025: 5.5×
FY 2016 5y median 2.7× FY 2025
P/B -2.4×
FY 2016: 0.0×FY 2017: 7.0×FY 2018: 12.6×FY 2019: 17.8×FY 2020: 6.2×FY 2021: 9.3×FY 2022: 3.8×FY 2023: -0.9×FY 2024: -1.0×FY 2025: -2.4×
FY 2016 5y median -0.9× FY 2025
P/FCF -3.2×
FY 2016: 0.0×FY 2017: -22.3×FY 2018: -12.9×FY 2019: -16.0×FY 2020: -12.2×FY 2021: -6.5×FY 2022: -2.2×FY 2023: -1.1×FY 2024: -1.6×FY 2025: -3.2×
FY 2016 5y median -2.2× FY 2025
EV/EBITDA -7.0×
FY 2016: 0.0×FY 2017: -16.2×FY 2018: -11.9×FY 2019: -16.4×FY 2020: -8.2×FY 2021: -5.3×FY 2022: -1.0×FY 2023: 0.1×FY 2024: -0.6×FY 2025: -7.0×
FY 2016 5y median -1.0× FY 2025
EV/Sales 7.7×
FY 2016: 0.0×FY 2017: 822×FY 2018: 1278×FY 2019: 800×FY 2020: 0.0×FY 2021: 36.1×FY 2022: 0.5×FY 2023: -0.3×FY 2024: 0.9×FY 2025: 7.7×
FY 2016 5y median 0.9× FY 2025
FCF Yield -31.5%
FY 2016: 0.0%FY 2017: -4.5%FY 2018: -7.8%FY 2019: -6.2%FY 2020: -8.2%FY 2021: -15.5%FY 2022: -45.8%FY 2023: -89.9%FY 2024: -64.5%FY 2025: -31.5%
FY 2016 5y median -45.8% FY 2025

Profitability

Gross Margin 90.6%
FY 2016: 0.0%FY 2017: -4643.8%FY 2018: -10258.4%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 95.9%FY 2022: 98.4%FY 2023: 96.4%FY 2024: 91.6%FY 2025: 90.6%
FY 2016 5y median 95.9% FY 2025
Operating Margin -133.2%
FY 2016: 0.0%FY 2017: -5084.3%FY 2018: -11047.5%FY 2019: -5102.5%FY 2020: 0.0%FY 2021: -771.6%FY 2022: -58.8%FY 2023: -238.6%FY 2024: -184.4%FY 2025: -133.2%
FY 2016 5y median -184.4% FY 2025
Net Margin -175.3%
FY 2016: 0.0%FY 2017: -4984.0%FY 2018: -10797.9%FY 2019: -4977.9%FY 2020: 0.0%FY 2021: -678.2%FY 2022: -74.9%FY 2023: -345.1%FY 2024: -222.8%FY 2025: -175.3%
FY 2016 5y median -222.8% FY 2025
ROE 76.7%
FY 2016: 0.0%FY 2017: -36.1%FY 2018: -97.5%FY 2019: -104.8%FY 2020: -73.4%FY 2021: -138.5%FY 2022: -197.8%FY 2023: 161.9%FY 2024: 77.9%FY 2025: 76.7%
FY 2016 5y median 76.7% FY 2025
ROIC -42.3%
FY 2016: 0.0%FY 2017: -36.5%FY 2018: -98.2%FY 2019: -100.4%FY 2020: -45.9%FY 2021: -43.4%FY 2022: -29.2%FY 2023: -57.5%FY 2024: -53.8%FY 2025: -42.3%
FY 2016 5y median -43.4% FY 2025
ROA -44.1%
FY 2016: 0.0%FY 2017: -33.0%FY 2018: -81.8%FY 2019: -84.6%FY 2020: -47.9%FY 2021: -37.2%FY 2022: -32.0%FY 2023: -67.7%FY 2024: -49.0%FY 2025: -44.1%
FY 2016 5y median -44.1% FY 2025

Growth (YoY)

Revenue 14.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -36.8%FY 2019: 105.3%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 518.9%FY 2023: -66.9%FY 2024: 1.8%FY 2025: 14.9%
FY 2016 FY 2025
Operating Income 17.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -37.4%FY 2019: 5.2%FY 2020: -83.6%FY 2021: -19.4%FY 2022: 52.9%FY 2023: -34.6%FY 2024: 21.3%FY 2025: 17.0%
FY 2016 FY 2025
EPS (diluted) 30.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -49.7%FY 2019: 24.0%FY 2020: -116.7%FY 2021: 20.4%FY 2022: 33.7%FY 2023: -47.7%FY 2024: 44.9%FY 2025: 30.9%
FY 2016 FY 2025
Free Cash Flow -13.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -58.6%FY 2019: 0.1%FY 2020: -38.6%FY 2021: -39.8%FY 2022: 42.7%FY 2023: 11.3%FY 2024: -2.3%FY 2025: -13.4%
FY 2016 FY 2025

Financial Health

Current Ratio 4.4×
FY 2016: 15.6×FY 2017: 12.9×FY 2018: 6.4×FY 2019: 6.1×FY 2020: 11.1×FY 2021: 7.1×FY 2022: 5.3×FY 2023: 5.0×FY 2024: 3.8×FY 2025: 4.4×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 4.3×
FY 2016: 15.6×FY 2017: 12.9×FY 2018: 6.3×FY 2019: 6.1×FY 2020: 11.1×FY 2021: 7.0×FY 2022: 5.2×FY 2023: 4.7×FY 2024: 3.6×FY 2025: 4.3×
FY 2016 5y median 4.7× FY 2025
Debt / Equity -2.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.8×FY 2022: 1.6×FY 2023: -0.8×FY 2024: -0.6×FY 2025: -2.4×
FY 2016 5y median -0.6× FY 2025
Net Debt / EBITDA -2.0×
FY 2016: 0.0×FY 2017: 2.9×FY 2018: 1.1×FY 2019: 1.0×FY 2020: 1.5×FY 2021: 1.4×FY 2022: 1.8×FY 2023: 1.1×FY 2024: 1.2×FY 2025: -2.0×
FY 2016 5y median 1.2× FY 2025
Interest Coverage -2.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -765×FY 2020: -44.5×FY 2021: -14.3×FY 2022: -3.4×FY 2023: -3.6×FY 2024: -2.6×FY 2025: -2.1×
FY 2016 5y median -3.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31